Literature DB >> 28615912

Carbamazepine: A Symptomatic Treatment of the Paresthesiae Associated with Lhermitte's Sign.

Karl Ekbom1.   

Abstract

Entities:  

Year:  2017        PMID: 28615912      PMCID: PMC5470169          DOI: 10.4103/aian.AIAN_21_17

Source DB:  PubMed          Journal:  Ann Indian Acad Neurol        ISSN: 0972-2327            Impact factor:   1.383


× No keyword cloud information.
Sir, I read with great interest the review article on Lhermitte's sign by Khare and Seth.[1] The sign occurs, inter alia, in multiple sclerosis, in traumatic lesions of the cervical cord, and in subacute combined degeneration. I agree that very few studies are available on Lhermitte's sign and there is need of more research in this particular field. In this current review, treatment with extracranial picotesla range pulsed electromagnetic fields was said to be effective. Neck brace and collar might also be prescribed by physical therapists, and exercises and relaxation technique were claimed to be helpful. I found that carbamazepine in a rather small dosage had an immediate symptomatic effect on the paresthesiae associated with Lhermitte's sign in three patients with multiple sclerosis.[2] In two of the patients, the symptoms reappeared when the treatment was discontinued. In two cases, the effect of the drug could be reproduced in several short series of treatment and was checked at each examination by letting the patient repeatedly bend his/her head forward in both a recumbent and sitting position. The therapeutic results in my cases resembled those obtained by carbamazepine in connection with the treatment of trigeminal neuralgia and spontaneous paroxysmal symptoms in multiple sclerosis such as painful tonic seizures and paroxysmal dysarthria.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  2 in total

1.  Carbamazepine, a new symptomatic treatment for the paraesthesiae associated with Lhermitte's sign.

Authors:  K Ekbom
Journal:  Z Neurol       Date:  1971

2.  Lhermitte's Sign: The Current Status.

Authors:  Supreet Khare; Deeksha Seth
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.